20 June 2013
Keywords: patients, vivus, qnexa, lose, 20lbs, placebo, study
Article | 22 May 2006
US drugmaker Vivus has reported positive results from a 200-patient, double-blind, placebo-controlled clinical trial of Qnexa (phentermine
and topiramate), its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 May 2006
19 June 2013
© 2013 thepharmaletter.com